Intragenic	O
enhancers	O
act	O
as	O
alternative	O
promoters	O
.	O


A	O
substantial	O
amount	O
of	O
organismal	O
complexity	O
is	O
thought	O
to	O
be	O
encoded	O
by	O
enhancers	O
which	O
specify	O
the	O
location	O
,	O
timing	O
,	O
and	O
levels	O
of	O
gene	O
expression	O
.	O


In	O
mammals	O
there	O
are	O
more	O
enhancers	O
than	O
promoters	O
which	O
are	O
distributed	O
both	O
between	O
and	O
within	O
genes	O
.	O


Here	O
we	O
show	O
that	O
activated	O
,	O
intragenic	O
enhancers	O
frequently	O
act	O
as	O
alternative	O
tissue	O
-	O
specific	O
promoters	O
producing	O
a	O
class	O
of	O
abundant	O
,	O
spliced	O
,	O
multiexonic	O
poly	O
(	O
A	O
)	O
(	O
+	O
)	O
RNAs	O
(	O
meRNAs	O
)	O
which	O
reflect	O
the	O
host	O
gene	O
'	O
s	O
structure	O
.	O
meRNAs	O
make	O
a	O
substantial	O
and	O
unanticipated	O
contribution	O
to	O
the	O
complexity	O
of	O
the	O
transcriptome	O
,	O
appearing	O
as	O
alternative	O
isoforms	O
of	O
the	O
host	O
gene	O
.	O


The	O
low	O
protein	O
-	O
coding	O
potential	O
of	O
meRNAs	O
suggests	O
that	O
many	O
meRNAs	O
may	O
be	O
byproducts	O
of	O
enhancer	O
activation	O
or	O
underlie	O
as	O
-	O
yet	O
-	O
unidentified	O
RNA	O
-	O
encoded	O
functions	O
.	O


Distinguishing	O
between	O
meRNAs	O
and	O
mRNAs	O
will	O
transform	O
our	O
interpretation	O
of	O
dynamic	O
changes	O
in	O
transcription	O
both	O
at	O
the	O
level	O
of	O
individual	O
genes	O
and	O
of	O
the	O
genome	O
as	O
a	O
whole	O
.	O
